
Poll|Articles|November 5, 2025
Poll: Has the Shortage of IV Ativan Impacted Your Practice?
Author(s)Psychiatric Times Editors
Listen
0:00 / 0:00
Key Takeaways
- The shortage of IV Ativan poses challenges in managing psychiatric conditions, particularly catatonia, necessitating alternative treatment strategies.
- Increased incidences of catatonia may occur due to the difficulty in accessing IV Ativan, impacting patient care.
Answer our poll!
Advertisement
Psychiatric Times contributors have noted a challenge in their psychiatric practice: the shortage of intravenous (IV) Ativan.
Has the shortage of IV Ativan impacted your practice?
Have you noticed an increase in catatonia amongst your patients?
If you have noticed an increase in catatonia or a difficulty in accessing IV Ativan, reach out to us at
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Depression and Long COVID Outcomes in Women: New Data Analysis
2
Presenting Our February 2026 Theme: Bipolar Disorder
3
Patterns of Propensity: A Review of Heinrichs’ How Psychiatrists Make Decisions
4
Investigational Psilocybin for PTSD and Ongoing Trials
5







